vs
德康医疗（DXCM）与Rithm Capital Corp.（RITM）财务数据对比。点击上方公司名可切换其他公司
德康医疗的季度营收约是Rithm Capital Corp.的1.5倍（$1.3B vs $828.2M），德康医疗净利率更高（21.2% vs 13.2%，领先8.0%），Rithm Capital Corp.同比增速更快（508.5% vs 21.6%），过去两年德康医疗的营收复合增速更高（12.0% vs -17.9%）
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
Rithm Capital Corp.是总部位于美国纽约的投资管理机构，核心业务聚焦房地产投资与另类资产投资，依托专业的投研团队和成熟的市场运营经验，为合作伙伴及投资者提供优质的资产配置解决方案与长期收益回报。
DXCM vs RITM — 直观对比
营收规模更大
DXCM
是对方的1.5倍
$828.2M
营收增速更快
RITM
高出486.9%
21.6%
净利率更高
DXCM
高出8.0%
13.2%
两年增速更快
DXCM
近两年复合增速
-17.9%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $828.2M |
| 净利润 | $267.3M | $109.5M |
| 毛利率 | 62.9% | — |
| 营业利润率 | 25.6% | 29.9% |
| 净利率 | 21.2% | 13.2% |
| 营收同比 | 21.6% | 508.5% |
| 净利润同比 | 153.6% | 27.7% |
| 每股收益（稀释后） | $0.67 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXCMRITM
| Q1 26 | $1.3B | $828.2M | ||
| Q4 25 | $1.3B | $1.5B | ||
| Q3 25 | $1.2B | $1.1B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $1.0B | $768.4M | ||
| Q4 24 | $1.1B | $2.1B | ||
| Q3 24 | $994.2M | $619.5M | ||
| Q2 24 | $1.0B | $1.2B |
净利润DXCMRITM
| Q1 26 | $267.3M | $109.5M | ||
| Q4 25 | $267.3M | $85.0M | ||
| Q3 25 | $283.8M | $221.5M | ||
| Q2 25 | $179.8M | $311.7M | ||
| Q1 25 | $105.4M | $78.8M | ||
| Q4 24 | $151.7M | $290.2M | ||
| Q3 24 | $134.6M | $121.7M | ||
| Q2 24 | $143.5M | $235.6M |
毛利率DXCMRITM
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
营业利润率DXCMRITM
| Q1 26 | 25.6% | 29.9% | ||
| Q4 25 | 25.6% | 13.8% | ||
| Q3 25 | 20.1% | 21.4% | ||
| Q2 25 | 18.4% | 25.2% | ||
| Q1 25 | 12.9% | 7.4% | ||
| Q4 24 | 17.0% | 23.8% | ||
| Q3 24 | 15.3% | 7.3% | ||
| Q2 24 | 15.7% | 23.6% |
净利率DXCMRITM
| Q1 26 | 21.2% | 13.2% | ||
| Q4 25 | 21.2% | 5.7% | ||
| Q3 25 | 23.5% | 20.0% | ||
| Q2 25 | 15.5% | 25.6% | ||
| Q1 25 | 10.2% | 10.3% | ||
| Q4 24 | 13.6% | 14.0% | ||
| Q3 24 | 13.5% | 19.7% | ||
| Q2 24 | 14.3% | 19.2% |
每股收益（稀释后）DXCMRITM
| Q1 26 | $0.67 | $0.12 | ||
| Q4 25 | $0.67 | $0.09 | ||
| Q3 25 | $0.70 | $0.35 | ||
| Q2 25 | $0.45 | $0.53 | ||
| Q1 25 | $0.27 | $0.07 | ||
| Q4 24 | $0.37 | $0.50 | ||
| Q3 24 | $0.34 | $0.20 | ||
| Q2 24 | $0.35 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.7B | $9.1B |
| 总资产 | $6.3B | $53.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DXCMRITM
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $1.8B | ||
| Q3 25 | $1.8B | $1.6B | ||
| Q2 25 | $1.2B | $1.6B | ||
| Q1 25 | $904.9M | $1.5B | ||
| Q4 24 | $606.1M | $1.5B | ||
| Q3 24 | $621.2M | $1.6B | ||
| Q2 24 | $939.2M | $1.2B |
总债务DXCMRITM
| Q1 26 | — | — | ||
| Q4 25 | — | $35.4B | ||
| Q3 25 | — | $32.2B | ||
| Q2 25 | — | $31.2B | ||
| Q1 25 | — | $32.2B | ||
| Q4 24 | — | $32.6B | ||
| Q3 24 | — | $29.6B | ||
| Q2 24 | — | $30.1B |
股东权益DXCMRITM
| Q1 26 | $2.7B | $9.1B | ||
| Q4 25 | $2.7B | $8.4B | ||
| Q3 25 | $2.7B | $8.5B | ||
| Q2 25 | $2.6B | $7.9B | ||
| Q1 25 | $2.3B | $7.8B | ||
| Q4 24 | $2.1B | $7.8B | ||
| Q3 24 | $2.0B | $7.7B | ||
| Q2 24 | $2.4B | $7.3B |
总资产DXCMRITM
| Q1 26 | $6.3B | $53.4B | ||
| Q4 25 | $6.3B | $53.1B | ||
| Q3 25 | $7.5B | $47.2B | ||
| Q2 25 | $7.3B | $44.3B | ||
| Q1 25 | $6.8B | $45.3B | ||
| Q4 24 | $6.5B | $46.0B | ||
| Q3 24 | $6.4B | $42.3B | ||
| Q2 24 | $6.8B | $42.0B |
负债/权益比DXCMRITM
| Q1 26 | — | — | ||
| Q4 25 | — | 4.20× | ||
| Q3 25 | — | 3.79× | ||
| Q2 25 | — | 3.92× | ||
| Q1 25 | — | 4.14× | ||
| Q4 24 | — | 4.18× | ||
| Q3 24 | — | 3.87× | ||
| Q2 24 | — | 4.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DXCM
暂无分部数据
RITM
| Servicing revenue, net | $375.1M | 45% |
| Other | $234.9M | 28% |
| Gain on originated residential mortgage loans, held-for-sale, net | $195.0M | 24% |
| Other revenue | $23.3M | 3% |
